These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 20533453

  • 1. Advances in platinum chemotherapeutics.
    Harper BW, Krause-Heuer AM, Grant MP, Manohar M, Garbutcheon-Singh KB, Aldrich-Wright JR.
    Chemistry; 2010 Jun 25; 16(24):7064-77. PubMed ID: 20533453
    [Abstract] [Full Text] [Related]

  • 2. Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin.
    Shi H, Cheng Q, Yuan S, Ding X, Liu Y.
    Chemistry; 2015 Nov 09; 21(46):16547-54. PubMed ID: 26405808
    [Abstract] [Full Text] [Related]

  • 3. Characterization and cellular uptake of platinum anticancer drugs encapsulated in apoferritin.
    Xing R, Wang X, Zhang C, Zhang Y, Wang Q, Yang Z, Guo Z.
    J Inorg Biochem; 2009 Jul 09; 103(7):1039-44. PubMed ID: 19501911
    [Abstract] [Full Text] [Related]

  • 4. Mono- and di-bromo platinum(IV) prodrugs via oxidative bromination: synthesis, characterization, and cytotoxicity.
    Xu Z, Wang Z, Yiu SM, Zhu G.
    Dalton Trans; 2015 Dec 14; 44(46):19918-26. PubMed ID: 26514681
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance.
    Kelland LR, Sharp SY, O'Neill CF, Raynaud FI, Beale PJ, Judson IR.
    J Inorg Biochem; 1999 Oct 14; 77(1-2):111-5. PubMed ID: 10626362
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Quantitative measurement of the reduction of platinum(IV) complexes using X-ray absorption near-edge spectroscopy (XANES).
    Hall MD, Daly HL, Zhang JZ, Zhang M, Alderden RA, Pursche D, Foran GJ, Hambley TW.
    Metallomics; 2012 Jun 14; 4(6):568-75. PubMed ID: 22569908
    [Abstract] [Full Text] [Related]

  • 14. Cellular processing of platinum anticancer drugs.
    Wang D, Lippard SJ.
    Nat Rev Drug Discov; 2005 Apr 14; 4(4):307-20. PubMed ID: 15789122
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oxaliplatin: mechanism of action and antineoplastic activity.
    Raymond E, Faivre S, Woynarowski JM, Chaney SG.
    Semin Oncol; 1998 Apr 14; 25(2 Suppl 5):4-12. PubMed ID: 9609103
    [Abstract] [Full Text] [Related]

  • 18. Comparison of platinum concentrations in human head and neck tumours following administration of carboplatin, iproplatin or cisplatin.
    Hecquet B, Caty A, Fournier C, Lefebvre JL, Adenis L.
    Bull Cancer; 1987 Apr 14; 74(4):433-6. PubMed ID: 3311237
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Platinum (IV)-coordinate polymers as intracellular reduction-responsive backbone-type conjugates for cancer drug delivery.
    Yang J, Liu W, Sui M, Tang J, Shen Y.
    Biomaterials; 2011 Dec 14; 32(34):9136-43. PubMed ID: 21889206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.